Sign in

CIK 0000310158 · Large accelerated filer

Merck & Co., Inc.

Sign in to watch
Ticker
MRK
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NJ
Entity type
operating
EIN
221918501
Phone
908-740-4000
Business address
126 EAST LINCOLN AVENUE, P.O. BOX 2000, RAHWAY, NJ, 07065
Former names
Merck & Co. Inc., SCHERING PLOUGH CORP
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-11-09 Davis Robert M CEO & President Sale −87,595 $101.94 $8.9M 327,610.76
2022-11-09 Davis Robert M CEO & President Sale −79,918 $102.98 $8.2M 247,692.76
2022-11-09 Davis Robert M CEO & President Sale −100 $103.59 $10K 247,592.76
2022-11-09 Davis Robert M CEO & President Option exercise · Stock Option (Right to Buy) −167,613 0
2022-11-08 MIZELL STEVEN EVP, Chief HR Officer Option exercise +20,000 52,144.15
2022-11-08 MIZELL STEVEN EVP, Chief HR Officer Sale −20,000 $101.00 $2.0M 32,144.15
2022-11-08 MIZELL STEVEN EVP, Chief HR Officer Option exercise · Stock Option (Right to Buy) −20,000 15,824
2022-11-07 FRAZIER KENNETH C Executive Chair Option exercise +235,769 936,422.06
2022-11-07 FRAZIER KENNETH C Executive Chair Sale −24,914 $98.45 $2.5M 911,508.06
2022-11-07 FRAZIER KENNETH C Executive Chair Sale −126,134 $99.42 $12.5M 785,374.06
2022-11-07 FRAZIER KENNETH C Executive Chair Sale −84,721 $100.07 $8.5M 700,653.06
2022-11-07 FRAZIER KENNETH C Executive Chair Option exercise · Stock Option (Right to Buy) −235,769 0

Page 29 of 29 · 572 trades